Comparison of Quantum Dot Biodistribution with a Blood-Flow-Limited Physiologically Based Pharmacokinetic Model

College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina 27606, USA.
Nano Letters (Impact Factor: 12.94). 02/2009; 9(2):794-9. DOI: 10.1021/nl803481q
Source: PubMed

ABSTRACT A physiologically based pharmacokinetic model with partition coefficients estimated from quantum dot (QD) 705 biodistribution was compared with the biodistribution of other QDs in mice and rats to determine the model's predictive ability across QD types, species, and exposure routes. The model predicted the experimentally observed persistence of QDs in tissues but not early time profiles or different QD biodistribution. Therefore, more complex models will be needed to better predict QD biodistribution in vivo.

Download full-text


Available from: Nancy A Monteiro-Riviere, Jul 07, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanotechnology offers a new platform for therapeutic delivery of antiretrovirals to the central nervous system (CNS). Nanoformulated antiretroviral drugs offer multifunctionality, that is, the ability to package multiple diagnostic and therapeutic agents in the same nanocompose, along with the added provisions of site-directed delivery, delivery across the blood-brain-barrier (BBB), and controlled release of therapeutics. We studied the viability of dendrimers and dendriplexes in human primary astrocytes, as well as their uptake by these astrocytes. Functional validation was performed by using specific siRNA against HIV-1 Nef to interfere to HIV-1 infectivity. A high efficiency in Nef silencing, reducing HIV-1 infectivity was observed in astrocytes treated with dendriplexes compared with control or siRandom treated astrocytes. More interestingly, we studied the biodistribution of the second generation of carbosilane dendrimer loaded with FITC (2G-(SNMe3I)11-FITC) in vivo, in BALB/c mice. Dendriplexes were inoculated into BALB/c mice by the retro-orbital venous plexus, and their localization was determined after 1 and 24h post-injection. Dendriplexes were detected inside the brain by a sensitive imaging system of fluorescent imaging in vivo (IVIS Lumina), and by confocal microscopy analysis of sections of OCT-embedded tissues. The 2G-(SNMe3I)11-FITC dendrimer transported efficiently siRNA into the brain, crossing the BBB. Moreover, this dendrimer successfully delivered and transfected siRNA to HIV-infected human primary astrocytes and achieved gene silencing without causing cytotoxicity. These results highlight the potential of this nanoformulation in the treatment of neurological disorders. Copyright © 2014. Published by Elsevier B.V.
    Journal of Controlled Release 01/2015; 200. DOI:10.1016/j.jconrel.2014.12.042 · 7.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanomaterials increasingly are playing a role in society for uses ranging from biomedicine to microelectronics; however, pharmacokinetic studies, which will be necessary for human health risk assessments, are limited. Currently the most widely used nanoparticle in consumer products is silver (Ag). The objective of the present study was to quantify the local biodistribution of two types of Ag nanoparticles, Ag-citrate and Ag-silica, in the isolated perfused porcine skin flap (IPPSF). IPPSFs were perfused for 4 h with 0.84 µg ml(-1) Ag-citrate or 0.48 µg ml(-1) Ag-silica followed by a 4-h perfusion with media only during a washout phase. Arterial and venous concentrations of Ag were measured in the media by inductively coupled plasma optical emission spectrometry (ICP-OES). Venous concentrations of Ag for both types of nanoparticles were best fit with a two compartment model. The normalized volumes of distribution estimated from the noncompartmental analysis of the venous concentrations indicated distribution of Ag greater than the vascular space; however, because total Ag was measured, the extravascular distribution could be attributed to diffusion of Ag ions. The estimated clearance for both types of Ag nanoparticles was 1 ml min(-1) , which was equal to the flap perfusion rate, indicating no detectable elimination of Ag from the system. Four hours after infusion of the Ag nanoparticles, the recovery of Ag in the venous effluent was 90 ± 5.0% and 87 ± 22 % of the infused Ag for Ag-citrate and Ag-silica, respectively. Copyright © 2012 John Wiley & Sons, Ltd.
    Journal of Applied Toxicology 11/2012; 32(11):913-9. DOI:10.1002/jat.2750 · 3.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Skin is an important route of exposure to chemicals after occupational, environmental and consumer product usage, routes also pertinent to nanomaterial exposure. Knowledge of the rate and extent of absorption is required for risk assessments to be made. The primary barrier to chemical absorption is the stratum corneum. The basic question to be answered is how nanomaterial absorption compares to existing paradigms of chemical absorption. Initial studies using topically applied quantum dots suggest that absorption is minimal, yet particle characteristics and species differences exist. If nanomaterial is absorbed via any route of administration, distribution to skin may also occur as was demonstrated in isolated perfused skin studies. Research is beginning to be conducted to define the mechanistic framework describing nanomaterials biodistribution using pharmacokinetic models.
    Nanotoxicology 09/2009; 3(3):188-193. DOI:10.1080/17435390902906803 · 7.34 Impact Factor